EVRALENT Trademark Information

Trademark by Glaxo Group Limited

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncolog...

Classification Information

Use in Commerce Trademark - Applicant has provided proof of use of this mark in commerce to USPTO.

Primary Class: Class Details:
Class (005)
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
First Use Anywhere:: Not provided
First Use In Commerce: Not provided
General Information
Word mark: EVRALENT
Status/Status Date:
REGISTERED
2/4/2020
Serial Number: 79263054
Filing Date: 5/16/2019
Registration Number: 5974602
Registration Date: 2/4/2020
Goods and Services: Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Mark Description: NOT AVAILABLE
Type Of Mark: TradeMark
Published For Opposition Date: 11/19/2019
Last Applicant/Owner:
Glaxo Group Limited
Mark Drawing Code: Standard Character Mark
Design Search:
(NO DATA)
Register Type: Principal
Disclaimer: (NOT AVAILABLE)
Correspondent:
GSK
LBP, 5.5A
5 MOORE DRIVE
RESEARCH TRIANGLE PARK NC 27709-3398
Current Status:
REGISTERED
2/4/2020
Correspondent Search:
Merilee J. Arevalo is a correspondent of EVRALENT trademark.
Current Overall Rating:
RatingRatingRatingRatingRating

(0 review)

As seen on